NO884795L - Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette. - Google Patents

Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.

Info

Publication number
NO884795L
NO884795L NO88884795A NO884795A NO884795L NO 884795 L NO884795 L NO 884795L NO 88884795 A NO88884795 A NO 88884795A NO 884795 A NO884795 A NO 884795A NO 884795 L NO884795 L NO 884795L
Authority
NO
Norway
Prior art keywords
recombinant
preparing
procedure
human immunoglobulin
immunoglobulin
Prior art date
Application number
NO88884795A
Other languages
English (en)
Other versions
NO884795D0 (no
Inventor
Linda J Harris
Leah A Lipsich
Michael A Walls
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO884795D0 publication Critical patent/NO884795D0/no
Publication of NO884795L publication Critical patent/NO884795L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO88884795A 1987-10-28 1988-10-27 Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette. NO884795L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11463287A 1987-10-28 1987-10-28
US25400488A 1988-09-16 1988-09-16

Publications (2)

Publication Number Publication Date
NO884795D0 NO884795D0 (no) 1988-10-27
NO884795L true NO884795L (no) 1989-04-28

Family

ID=26812406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884795A NO884795L (no) 1987-10-28 1988-10-27 Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.

Country Status (10)

Country Link
EP (1) EP0314161A1 (no)
JP (1) JPH02138989A (no)
AU (2) AU634151B2 (no)
DK (1) DK597288A (no)
FI (1) FI884924A (no)
IL (1) IL88175A0 (no)
MY (1) MY104344A (no)
NO (1) NO884795L (no)
NZ (1) NZ226694A (no)
PT (1) PT88874B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63267295A (ja) * 1986-12-03 1988-11-04 Sumitomo Chem Co Ltd ヒト抗体、抗体遺伝子及び対応する組換え体
US5610034A (en) * 1987-04-29 1997-03-11 Alko Group Ltd. Immunoglobulin production by trichoderma
JPH05500608A (ja) * 1989-09-19 1993-02-12 セントカー・インコーポレーテツド ヒトモノクローナル抗体の産生を改良する方法
AU648056B2 (en) * 1989-11-07 1994-04-14 Bristol-Myers Squibb Company Oligomeric immunoglobulins
AU657911B2 (en) * 1990-07-16 1995-03-30 Roal Oy Immunoglobulin production by (Trichoderma)
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
ATE243747T1 (de) * 1991-07-15 2003-07-15 Wellcome Found Herstellung von antikörpern
CA2078539C (en) 1991-09-18 2005-08-02 Kenya Shitara Process for producing humanized chimera antibody
CA2105618C (en) * 1992-09-07 2009-11-03 Kazuyasu Nakamura Humanized antibodies to ganglioside gm2
US6042828A (en) 1992-09-07 2000-03-28 Kyowa Hakko Kogyo Co., Ltd. Humanized antibodies to ganglioside GM2
US5939532A (en) * 1993-09-07 1999-08-17 Kyowa Hakko Kogyo Co., Ltd Humanized antibodies to ganglioside GM2
US6130364A (en) * 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
WO2002014504A1 (fr) 2000-08-11 2002-02-21 Kirin Beer Kabushiki Kaisha Polypeptides de regulation du metabolisme de l'acide phosphorique, du metabolisme du calcium, du metabolisme de la calcification et de la vitamine d et des adn codant pour de tels polypeptides
EP2011802A3 (en) 2001-04-27 2009-04-15 Kyowa Hakko Kirin Co., Ltd. Anti-CD40 monoclonal antibody
CN100519584C (zh) 2001-12-28 2009-07-29 麒麟医药株式会社 抗成纤维细胞生长因子23的抗体
ES2442615T5 (es) 2002-07-18 2023-03-16 Merus Nv Producción recombinante de mezclas de anticuerpos
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
NZ548325A (en) 2003-12-25 2009-07-31 Kirin Pharma Kk Mutants of anti-CD40 antibody
WO2005068622A2 (en) 2004-01-20 2005-07-28 Merus B.V. Mixtures of binding proteins
EP2145954A1 (en) 2004-09-06 2010-01-20 Kyowa Hakko Kirin Co., Ltd. Anti-A33 antibody
TW200808347A (en) 2006-03-23 2008-02-16 Kirin Brewery Agonistic antibody directed against human thrombopoietin receptor
TWI390034B (zh) 2006-04-06 2013-03-21 Kyowa Hakko Kirin Co Ltd Novel anti-CD98 antibody
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7883705B2 (en) 2007-02-14 2011-02-08 Kyowa Hakko Kirin Co., Ltd. Anti FGF23 antibody and a pharmaceutical composition comprising the same
US8124093B2 (en) 2008-07-16 2012-02-28 Institute For Research In Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof
KR20230093359A (ko) 2012-04-20 2023-06-27 메뤼스 엔.페. Ig-유사 분자의 제조방법 및 제조수단
WO2014006217A1 (en) 2012-07-06 2014-01-09 Genmab B.V. Dimeric protein with triple mutations
ES2540753T3 (es) * 2012-09-24 2015-07-13 Lonza Biologics Plc. Vectores de expresión que comprenden secuencias quiméricas de promotor y amplificador de citomegalovirus
JP6471095B2 (ja) 2012-09-27 2019-02-20 メルス ナムローゼ フェンノートシャップ Ｔ細胞エンゲージャーとしての二重特異性ＩｇＧ抗体
EA201691438A1 (ru) 2014-02-28 2017-04-28 Мерус Н.В. Антитело, которое связывается с erbb-2 и erbb-3
JP6771385B2 (ja) 2014-02-28 2020-10-21 メルス ナムローゼ フェンノートシャップ 二重特異性抗体および医薬組成物
EP3345928B1 (en) 2015-07-10 2020-06-24 Merus N.V. Human cd3 binding antibody
MX2018004988A (es) 2015-10-23 2018-11-09 Merus Nv Moleculas de union que inhibe el crecimiento de cancer.
SG11201908971RA (en) 2017-03-31 2019-10-30 Merus Nv Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
BR112020002695A2 (pt) 2017-08-09 2020-08-25 Merus N.V. anticorpos que se ligam à egfr e cmet
JP7230819B2 (ja) 2017-10-06 2023-03-01 小野薬品工業株式会社 二重特異性抗体
TWI804572B (zh) 2018-02-09 2023-06-11 日商小野藥品工業股份有限公司 雙特異性抗體
TW202102544A (zh) 2019-04-04 2021-01-16 日商小野藥品工業股份有限公司 雙特異性抗體
WO2021006199A1 (ja) 2019-07-05 2021-01-14 小野薬品工業株式会社 Ｐｄ－１／ｃｄ３二重特異性タンパク質による血液がん治療
AU2020322765A1 (en) 2019-07-30 2022-02-24 Ono Pharmaceutical Co., Ltd. Bispecific antibody
TW202120550A (zh) 2019-08-08 2021-06-01 日商小野藥品工業股份有限公司 雙特異性蛋白質

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
WO1987002671A1 (en) * 1985-11-01 1987-05-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use

Also Published As

Publication number Publication date
AU2436388A (en) 1989-06-01
JPH02138989A (ja) 1990-05-28
FI884924A (fi) 1989-04-29
AU634151B2 (en) 1993-02-18
PT88874A (pt) 1989-07-31
AU2608292A (en) 1992-12-17
IL88175A0 (en) 1989-06-30
FI884924A0 (fi) 1988-10-25
EP0314161A1 (en) 1989-05-03
PT88874B (pt) 1994-01-31
DK597288D0 (da) 1988-10-27
DK597288A (da) 1989-04-29
NZ226694A (en) 1994-04-27
NO884795D0 (no) 1988-10-27
MY104344A (en) 1994-03-31

Similar Documents

Publication Publication Date Title
NO884795L (no) Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO871025D0 (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
NO884733D0 (no) Roermuffe og fremgangsmaate til fremstilling av samme.
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
NO882766D0 (no) Katalysatorer og fremgangsmaate for deres fremstilling.
NO855026L (no) Aminoacyllabdaner og fremgangsmaate til fremstilling derav.
DK169987D0 (da) Human tumor-associated antigen, ca-ou1
NO864194D0 (no) Slipekorn og fremgangsmaate til fremstilling derav.
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
DE3853743D1 (de) Rekombinanter menschlicher ADF.
NO870210L (no) Fremgangsmaate og anordning for avskinning.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
NO872587D0 (no) Forbedret limpreparat og fremgangsmaate for fremstilling av dette.
NO880292L (no) Fremgangsmaate for behandling av humle.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO853519L (no) Tannpleiemiddel og fremgangsmaate for fremstilling av dette.
NO912192L (no) Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
NO860428L (no) Engangshanske og fremgangsmaate for fremstilling av samme.
NO845134L (no) Dialkanoyloksybenzyliden-dialkanoat og fremgangsmaate til fremstilling derav.
NO872765L (no) Beta-laktam-sammensetning, og framgangsmaate for framstilling av denne.
NO883363L (no) Nytt diosminderivat og fremgangsmaate for fremstilling av dette.
NO873274D0 (no) Tettet roerskjoet og fremgangsmaate for dannelse av denne.
IT8720970A0 (it) Procedimento per preparare carnitossi-carnitina e acetilcarnitossi-carnitina.